Example: tourism industry
1 NEW ZEALAND DATA SHEET - Medsafe Home Page
Crestor Data Sheet 190618 Copyright 3 Use in children In children and adolescents with homozygous familial hypercholesterolaemia experience is limited to a small ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Drug-induced rhabdomyolysis
www.charlydmiller.comDrug-induced rhabdomyolysis Teresa J. Coco and Ann E. Klasner Purpose of review Drug-induced rhabdomyolysis is a common syndrome that …
DRUG NAME: Pembrolizumab - bccancer.bc.ca
www.bccancer.bc.caare a spectrum of side effects caused by general immunologic enhancement that can occur at any time during pembrolizumab treatment or months after discontinuation.
Chronic Renal Failure - - RN.org®
www.rn.orgIn stage 1, the focus is on identifying the disease and starting appropriate treatment measures. It is important to define the etiology of the disease, as this
Concerns of Addiction to Anaesthesiologists in the ...
medcraveonline.comJournal of Anesthesia & Critical Care: Open Access Concerns of Addiction to Anaesthesiologists in the Perioperative Period Volume 2 Issue 2 - 2015
GUIDELINE ORIGINAL ARTICLE GUIDELINE Adult …
www.sahivsoc.orgGUIDELINE DECEMBER 2014, Vol. 15, No. 4 SAJHIVMED 121 ORIGINAL ARTICLE GUIDELINE Adult antiretroviral therapy guidelines 2014 By the Southern African HIV Clinicians Society